180 related articles for article (PubMed ID: 28807246)
21. TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.
Fiorentini G; Aliberti C; Benea G; Montagnani F; Mambrini A; Ballardini PL; Cantore M
Hepatogastroenterology; 2008; 55(88):2077-82. PubMed ID: 19260480
[TBL] [Abstract][Full Text] [Related]
22. Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients.
Ngo A; von Stempel C; Corbo B; Bandula S; Shiu KK; Raja J; Hague J; Evans J; Kibrya N
Cardiovasc Intervent Radiol; 2019 Jul; 42(7):979-990. PubMed ID: 31044294
[TBL] [Abstract][Full Text] [Related]
23. Bradycardia associated with drug-eluting beads loaded with irinotecan (DEBIRI) infusion for colorectal liver metastases.
Pua U
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):864-6. PubMed ID: 22722719
[TBL] [Abstract][Full Text] [Related]
24. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases.
Zhao G; Liu S; Zhang Y; Zhao T; Wang R; Bian J; Wu J; Zhou J
Ir J Med Sci; 2022 Jun; 191(3):1139-1145. PubMed ID: 34264426
[TBL] [Abstract][Full Text] [Related]
25. The power of genes: a case of unusually severe systemic toxicity after localized hepatic chemoembolization with irinotecan-eluted microspheres for metastatic colon cancer.
Cruz JE; Saksena R; Jabbour SK; Nosher JL; Hermes-DeSantis E; Moss RA
Ann Pharmacother; 2014 Dec; 48(12):1646-50. PubMed ID: 25202035
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.
Ishikawa T; Imai M; Sato R; Jimbo R; Kobayashi Y; Sato T; Iwanaga A; Sano T; Yokoyama J; Honma T
Anticancer Res; 2023 Aug; 43(8):3647-3651. PubMed ID: 37500124
[TBL] [Abstract][Full Text] [Related]
27. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.
Bower M; Metzger T; Robbins K; Tomalty D; Válek V; Boudný J; Andrasina T; Tatum C; Martin RC
HPB (Oxford); 2010 Feb; 12(1):31-6. PubMed ID: 20495642
[TBL] [Abstract][Full Text] [Related]
28. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
[TBL] [Abstract][Full Text] [Related]
29. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
[TBL] [Abstract][Full Text] [Related]
30. Concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer.
Akinwande O; Miller A; Hayes D; O'Hara R; Tomalty D; Martin RC
Anticancer Res; 2014 Dec; 34(12):7239-45. PubMed ID: 25503155
[TBL] [Abstract][Full Text] [Related]
31. Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study.
Pernot S; Pellerin O; Artru P; Montérymard C; Smith D; Raoul JL; De La Fouchardière C; Dahan L; Guimbaud R; Sefrioui D; Jouve JL; Lepage C; Tougeron D; Taieb J;
Br J Cancer; 2020 Aug; 123(4):518-524. PubMed ID: 32507854
[TBL] [Abstract][Full Text] [Related]
32. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).
de Baere T; Tselikas L; Boige V; Ducreux M; Malka D; Goéré D; Benahim E; Deschamps F
Bull Cancer; 2017 May; 104(5):402-406. PubMed ID: 27993355
[TBL] [Abstract][Full Text] [Related]
33. Segmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.
Jones RP; Dunne D; Sutton P; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Koelblinger C; Stättner S; Stremitzer S; Gruenberger T; Poston GJ
HPB (Oxford); 2013 Jan; 15(1):71-7. PubMed ID: 23216781
[TBL] [Abstract][Full Text] [Related]
34. Fluorouracil, leucovorin and irinotecan combined with intra-arterial hepatic infusion of drug-eluting beads preloaded with irinotecan in unresectable colorectal liver metastases: side effects and results of a concomitant treatment schedule. Clinical investigation.
Kekez D; Badzek S; Prejac J; Gorsic I; Golem H; Librenjak N; Perkov D; Smiljanic R; Plestina S
Tumori; 2014; 100(5):499-503. PubMed ID: 25343542
[TBL] [Abstract][Full Text] [Related]
35. First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).
Eichler K; Zangos S; Mack MG; Hammerstingl R; Gruber-Rouh T; Gallus C; Vogl TJ
Int J Oncol; 2012 Oct; 41(4):1213-20. PubMed ID: 22842404
[TBL] [Abstract][Full Text] [Related]
36. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.
Fiorentini G; Aliberti C; Turrisi G; Del Conte A; Rossi S; Benea G; Giovanis P
In Vivo; 2007; 21(6):1085-91. PubMed ID: 18210761
[TBL] [Abstract][Full Text] [Related]
37. Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.
Martin RC; Howard J; Tomalty D; Robbins K; Padr R; Bosnjakovic PM; Tatum C
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):960-6. PubMed ID: 20661569
[TBL] [Abstract][Full Text] [Related]
38. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.
Morise Z; Sugioka A; Kato R; Fujita J; Hoshimoto S; Kato T
J Gastrointest Surg; 2006 Feb; 10(2):249-58. PubMed ID: 16455458
[TBL] [Abstract][Full Text] [Related]
39. Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and Outcomes.
Voizard N; Ni T; Kiss A; Pugash R; Raphael MJ; Coburn N; David E
Curr Oncol; 2022 Jan; 29(1):209-220. PubMed ID: 35049694
[TBL] [Abstract][Full Text] [Related]
40. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.
Vogl TJ; Gruber T; Balzer JO; Eichler K; Hammerstingl R; Zangos S
Radiology; 2009 Jan; 250(1):281-9. PubMed ID: 19092099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
